RecruitingNot applicableNCT03466463
Gene Therapy for Severe Crigler Najjar Syndrome
Studying Crigler-Najjar syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Genethon
- Principal Investigator
- LABRUNE Philippe, ProfHopital Antoine Beclere
- Intervention
- GNT0003(genetic)
- Enrollment
- 17 enrolled
- Eligibility
- 9 years · All sexes
- Timeline
- 2018 – 2030
Study locations (4)
- Hopital Antoine BECLERE, Clamart, France
- ASST Papa Giovanni XXIII, Bergamo, Italy
- Azienda Ospedaliera Universitaria Federico II, Naples, Italy
- AMC, Amsterdam, Netherlands
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03466463 on ClinicalTrials.gov